• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症小鼠模型大脑纹状体和皮质区域的蛋白质表达

Protein expression in the striatum and cortex regions of the brain for a mouse model of Huntington's disease.

作者信息

Liu Xiaoyun, Miller Benjamin R, Rebec George V, Clemmer David E

机构信息

Department of Chemistry, Indiana University, Bloomington, Indiana 47405, USA.

出版信息

J Proteome Res. 2007 Aug;6(8):3134-42. doi: 10.1021/pr070092s. Epub 2007 Jul 11.

DOI:10.1021/pr070092s
PMID:17625815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2577606/
Abstract

Liquid chromatography (LC) coupled with mass spectrometry (MS) and database assignment methods have been used to conduct a large-scale proteome survey of the R6/2 mouse model of Huntington's disease (HD). Although the neuropathological mechanisms of HD are not known, the mutant huntingtin gene that causes the disease is thought to alter gene transcription, leading to a cascade of neurotoxic events. In this report, we have focused on characterizing changes in the brain proteome associated with HD pathophysiology. Differences in the relative abundances of proteins (R6/2 compared to wild type) in brain tissue from the striatum and cortex, two primary loci of dysfunction in HD, were assessed by using a label-free approach based on calibrations to internal standards. In total, assignments were made for approximately 400 proteins. A set of criteria was used to establish 160 high confidence assignments, approximately 30% of which appear to show differences in expression relative to wild type (WT) animals. Many of the proteins that were differentially expressed are known to be associated with neurotransmission and likely play key roles in HD etiology. This study is the first to report that the majority of differentially expressed proteins in the striatum are up-regulated, while the majority of the expressed proteins in the cortex are down-regulated. The differentially expressed proteins identified in this proteomic screen may be potential biomarkers and drug targets for HD and may further our understanding of the disease pathology.

摘要

液相色谱(LC)与质谱(MS)联用以及数据库匹配方法已被用于对亨廷顿舞蹈病(HD)的R6/2小鼠模型进行大规模蛋白质组学研究。尽管HD的神经病理学机制尚不清楚,但人们认为导致该疾病的突变亨廷顿基因会改变基因转录,进而引发一系列神经毒性事件。在本报告中,我们着重于表征与HD病理生理学相关的脑蛋白质组变化。通过基于内标校准的无标记方法,评估了来自纹状体和皮质(HD中两个主要功能障碍位点)的脑组织中蛋白质相对丰度的差异(R6/2与野生型相比)。总共鉴定了约400种蛋白质。使用一组标准确定了160个高可信度的鉴定结果,其中约30%相对于野生型(WT)动物似乎表现出表达差异。许多差异表达的蛋白质已知与神经传递有关,并且可能在HD病因学中起关键作用。本研究首次报道,纹状体中大多数差异表达的蛋白质上调,而皮质中大多数差异表达的蛋白质下调。在该蛋白质组学筛选中鉴定出的差异表达蛋白质可能是HD的潜在生物标志物和药物靶点,并可能加深我们对该疾病病理的理解。

相似文献

1
Protein expression in the striatum and cortex regions of the brain for a mouse model of Huntington's disease.亨廷顿舞蹈症小鼠模型大脑纹状体和皮质区域的蛋白质表达
J Proteome Res. 2007 Aug;6(8):3134-42. doi: 10.1021/pr070092s. Epub 2007 Jul 11.
2
Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.Foxp1表达降低作为亨廷顿舞蹈病的一个促成因素
J Neurosci. 2017 Jul 5;37(27):6575-6587. doi: 10.1523/JNEUROSCI.3612-16.2017. Epub 2017 May 26.
3
Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.亨廷顿舞蹈病小鼠纹状体细胞模型与对照的差异蛋白质组学和基因组分析;对疾病生物学的可能影响。
J Proteomics. 2016 Jan 30;132:155-66. doi: 10.1016/j.jprot.2015.11.007. Epub 2015 Nov 12.
4
Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.野生型和敲入Q140/Q140亨廷顿舞蹈病小鼠大脑的质谱分析揭示了甘油磷脂的变化,包括磷脂酸和溶血磷脂酸的改变。
J Huntingtons Dis. 2015;4(2):187-201. doi: 10.3233/JHD-150149.
5
Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.在亨廷顿舞蹈病R6/1小鼠模型中脑胆固醇合成与代谢逐渐紊乱:靶向气相色谱-串联质谱甾醇分析
J Huntingtons Dis. 2015;4(4):305-18. doi: 10.3233/JHD-150170.
6
Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington's disease mice.蛋白激酶CβII信使核糖核酸水平在转基因亨廷顿舞蹈病小鼠的纹状体和皮质中降低。
J Psychiatry Neurosci. 2001 Mar;26(2):117-22.
7
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.亨廷顿舞蹈病遗传模型中腺苷A1受体的表达、药理学及功能活性
Neurobiol Dis. 2014 Nov;71:193-204. doi: 10.1016/j.nbd.2014.08.013. Epub 2014 Aug 15.
8
Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.用 BET 溴结构域抑制剂 JQ1 进行治疗,对 R6/2 亨廷顿病小鼠具有选择性的有害作用。
Hum Mol Genet. 2020 Jan 15;29(2):202-215. doi: 10.1093/hmg/ddz264.
9
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.亨廷顿病患者大脑中糖原合酶激酶-3和坍塌反应调节蛋白-2的局部变化。
Hum Mol Genet. 2014 Aug 1;23(15):4051-63. doi: 10.1093/hmg/ddu119. Epub 2014 Mar 14.
10
Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice.亨廷顿舞蹈病转基因小鼠对甲基苯丙胺、氟哌啶醇和喹啉酸的即刻早期基因反应未受损。
J Neurosci Res. 2002 Feb 1;67(3):372-8. doi: 10.1002/jnr.10100.

引用本文的文献

1
Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington's Disease Progression.阶段特异性血清蛋白质组学特征揭示亨廷顿舞蹈病进展中的早期生物标志物和分子途径。
Cells. 2025 Aug 4;14(15):1195. doi: 10.3390/cells14151195.
2
An integrated microfluidic and fluorescence platform for probing in vivo neuropharmacology.一种用于探究体内神经药理学的集成微流控与荧光平台。
Neuron. 2025 May 21;113(10):1491-1506.e6. doi: 10.1016/j.neuron.2025.03.017. Epub 2025 Apr 10.
3
Taming the Huntington's Disease Proteome: What Have We Learned?驯服亨廷顿舞蹈病蛋白质组:我们学到了什么?
J Huntingtons Dis. 2021;10(2):239-257. doi: 10.3233/JHD-200465.
4
New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease.用于蛋白质相对定量的新型无标记方法在亨廷顿病动物模型研究中的应用。
PLoS One. 2020 Sep 4;15(9):e0238037. doi: 10.1371/journal.pone.0238037. eCollection 2020.
5
Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.突变型亨廷顿蛋白通过与 TIM23 相互作用破坏线粒体蛋白质稳态。
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16593-16602. doi: 10.1073/pnas.1904101116. Epub 2019 Jul 25.
6
Role of NADPH oxidase-2 in the progression of the inflammatory response secondary to striatum excitotoxic damage.NADPH 氧化酶-2 在纹状体兴奋毒性损伤继发炎症反应进展中的作用。
J Neuroinflammation. 2019 Apr 17;16(1):91. doi: 10.1186/s12974-019-1478-4.
7
The heat shock response in neurons and astroglia and its role in neurodegenerative diseases.神经元和星形胶质细胞的热休克反应及其在神经退行性疾病中的作用。
Mol Neurodegener. 2017 Sep 18;12(1):65. doi: 10.1186/s13024-017-0208-6.
8
Anatomo-proteomic characterization of human basal ganglia: focus on striatum and globus pallidus.人类基底神经节的解剖蛋白质组学特征:聚焦于纹状体和苍白球。
Mol Brain. 2014 Nov 18;7:83. doi: 10.1186/s13041-014-0083-9.
9
Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.纹状体细胞的蛋白稳态与亨廷顿病的选择性神经退行性变。
Front Cell Neurosci. 2014 Aug 7;8:218. doi: 10.3389/fncel.2014.00218. eCollection 2014.
10
Quantitative measurement of phosphoproteome response to osmotic stress in arabidopsis based on Library-Assisted eXtracted Ion Chromatogram (LAXIC).基于文库辅助提取离子色谱(LAXIC)的拟南芥渗透胁迫磷酸化蛋白质组响应的定量测量。
Mol Cell Proteomics. 2013 Aug;12(8):2354-69. doi: 10.1074/mcp.O113.027284. Epub 2013 May 8.

本文引用的文献

1
Mapping the human plasma proteome by SCX-LC-IMS-MS.通过强阳离子交换液相色谱-离子淌度质谱联用技术绘制人类血浆蛋白质组图谱。
J Am Soc Mass Spectrom. 2007 Jul;18(7):1249-64. doi: 10.1016/j.jasms.2007.04.012. Epub 2007 Apr 24.
2
Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach.通过酸可裂解同位素编码亲和标签方法系统揭示亨廷顿病病理学的多种潜在途径。
Mol Cell Proteomics. 2007 May;6(5):781-97. doi: 10.1074/mcp.M600356-MCP200. Epub 2007 Jan 31.
3
Protein expression in a Drosophila model of Parkinson's disease.帕金森病果蝇模型中的蛋白质表达。
J Proteome Res. 2007 Jan;6(1):348-57. doi: 10.1021/pr060488o.
4
Toward plasma proteome profiling with ion mobility-mass spectrometry.迈向基于离子淌度-质谱联用的血浆蛋白质组分析
J Proteome Res. 2006 Nov;5(11):2977-84. doi: 10.1021/pr060232i.
5
Differential analysis of membrane proteins in mouse fore- and hindbrain using a label-free approach.使用无标记方法对小鼠前脑和后脑的膜蛋白进行差异分析。
J Proteome Res. 2006 Oct;5(10):2701-10. doi: 10.1021/pr060190y.
6
Inhibitors of the HSP90 molecular chaperone: current status.热休克蛋白90(HSP90)分子伴侣抑制剂:现状
Adv Cancer Res. 2006;95:323-48. doi: 10.1016/S0065-230X(06)95009-X.
7
DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.对有症状的转基因亨廷顿病小鼠(R6/2)纹状体基因表达进行的DNA微阵列分析揭示了神经炎症与胰岛素之间的关联。
Brain Res. 2006 May 9;1088(1):176-86. doi: 10.1016/j.brainres.2006.02.102. Epub 2006 Apr 19.
8
Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy.通过高分辨率魔角旋转1H核磁共振波谱对亨廷顿舞蹈病R6/2转基因小鼠模型进行代谢特征分析。
J Proteome Res. 2006 Mar;5(3):483-92. doi: 10.1021/pr050244o.
9
Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment.利用全局蛋白质组分析并辅以半胱氨酰肽富集对小鼠脑蛋白质组进行表征。
J Proteome Res. 2006 Feb;5(2):361-9. doi: 10.1021/pr0503681.
10
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.亨廷顿舞蹈病中纹状体富集mRNA表达的选择性缺陷
J Neurochem. 2006 Feb;96(3):743-57. doi: 10.1111/j.1471-4159.2005.03588.x. Epub 2006 Jan 9.